Ventricular Assist Devices Effectively Bridge Pediatric Patients to Heart Retransplantation: An ACTION Registry Study
The use of ventricular assist devices (VAD) in pediatric patients as a bridge to heart transplantation has increased over the past two decades. However, the use of VAD to bridge pediatric transplant recipients to retransplantation is rare and under-studied. We performed a retrospective study using the Advanced Cardiac Therapies Improving Outcomes Network (ACTION) registry to evaluate patient characteristics and clinical outcomes in patients bridged to retransplant with VAD. A total of 24 patients were identified and supported for a median duration of 64 days (interquartile range [IQR]: 15.0-101.25). Of these, 54% (n = 13) were implanted as a bridge to retransplant candidacy (BTC) and 46% (n = 11) as a bridge to retransplant (BTT). We found a high prevalence of major adverse events, including infection in 75% (n = 18), bleeding in 42% (n = 10), renal dysfunction requiring dialysis in 33% (n = 8), and stroke in 8% (n = 2). Despite this, 71% (n = 17) survived to retransplant, with an 88% 1 year survival following retransplant. Device mortality was higher in BTC compared to BTT (46% vs. 9%; p = 0.046). Our study is the first multicenter study evaluating the use of VAD as a BTT. We exhibit a high prevalence of adverse events on VAD, but a favorable waitlist and post-retransplant survival.
Authors
- Hanna John J Tadros (ORCID: https://orcid.org/0000-0002-2348-9262)
- Joseph A. Spinner (ORCID: https://orcid.org/0000-0001-9539-6252)
- Anna Joong (ORCID: https://orcid.org/0000-0003-2223-0045)
- Stevan Lukich
- on behalf of ACTION Learning Network Investigators
Institutions
- Lurie Children's Hospital (US)
- Baylor College of Medicine (US)
- Lurie Children's Hospital (US)
- Texas Children's Hospital (US)
Publication Details
- Journal
- ASAIO Journal
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1097/mat.0000000000002921
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.00